Dysmyelinated Lower Motor Neurons Retract and Regenerate Dysfunctional Synaptic Terminals

Journal of Neuroscience

Volumn 24, Issue 15, 2004, Pages 3890-3898

  Yin, Xinghua ^a   Kidd, Grahame J ^a   Pioro, Erik P ^a   McDonough, Jennifer ^a   Dutta, Ranjan ^a   Feltri, M Laura ^b   Wrabetz, Lawrence ^b   Messing, Albee ^c   Wyatt, Ryan M ^d   Balice Gordon, Rita J ^d   Trapp, Bruce D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acetylcholine receptor; Axon; Axonal sprouting; Dysmyelination; Myelin; Neuromuscular junction

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; MINIATURE ENDPLATE POTENTIAL; MOTONEURON; MOUSE; MUSCLE CELL; NERVE FIBER DEGENERATION; NEUROLOGIC DISEASE; NEUROMUSCULAR SYNAPSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SYNAPTIC MEMBRANE; TRANSGENIC ANIMAL;

ANIMALS; DEMYELINATING DISEASES; DISABILITY EVALUATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROMYOGRAPHY; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYELIN P0 PROTEIN; NERVE REGENERATION; NEUROMUSCULAR JUNCTION; PRESYNAPTIC TERMINALS; SCHWANN CELLS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES;

EID: 11144355226     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4617-03.2004     Document Type: Article

References (53)

1. Albuquerque EX, Rash JE, Mayer RF, Satterfield JR (1976) An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis. Exp Neurol 51:536-563.
2. Balice-Gordon RJ, Chua CK, Nelson CC, Lichtman JW (1993) Gradual loss of synaptic cartels precedes axon withdrawal at developing neuromuscular junctions. Neuron 11:801-815.
3. Balice-Gordon RJ, Smith DB, Goldman J, Cork LC, Shirley A, Cope TC, Pinter MJ (2000) Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease. Ann Neurol 47:596-605.
4. Berg DK, Hall ZW (1975) Loss of alpha-bungarotoxin from junctional and extrajunctional acetylcholine receptors in rat diaphragm muscle in vivo and in organ culture. J Physiol (Lond) 252:771-789.
5. Betz W, Osborne M (1977) Effects of innervation on acetylcholine sensitivity of developing muscle in vitro. J Physiol (Lond) 270:75-88.
6. Blazej RG, Mellersh CS, Cork LC, Ostrander EA (1998) Hereditary canine spinal muscular atrophy is phenotypically similar but molecularly distinct from human spinal muscular atrophy. J Hered 89:531-537.
7. Blondet B, Rieger F, Verdiere-Sahugue M (1989) Activity-independent modulation of acetylcholine receptor levels in rat skeletal muscle following neonatal denervation. Neurosci Lett 102:273-278.
8. Brady ST, Witt AS, Kirkpatrick LL, de Waegh SM, Readhead C, Tu PH, Lee VM (1999) Formation of compact myelin is required for maturation of the axonal cytoskeleton. J Neurosci 19:7278-7288.
9. Brown MC, Lunn ER, Perry VH (1992) Consequences of slow Wallerian degeneration for regenerating motor and sensory axons. J Neurobiol 23:521-536.
10. Cochilla AJ, Angleson JK, Betz WJ (1999) Monitoring secretory membrane with FM1-43 fluorescence. Annu Rev Neurosci 22:1-10.
11. Colman H, Nabekura J, Lichtman JW (1997) Alterations in synaptic strength preceding axon withdrawal. Science 275:356-361.
12. de Waegh SM, Lee VM, Brady ST (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451-463.
13. DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinetz E, Compton DL, Rojas E, Park JS, Smith C, DiStefano PS, Glass DJ, Burden SJ, Yancopoulos GD (1996) The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85:501-512.
14. Del Castillo J, Katz B (1954) Quantal components of the end-plate potential. J Physiol (Lond) 124:560-573.
15. Dyck PJ, Karnes JL, Lambert EH (1989) Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 39:1302-1308.
16. Fambrough DM (1974) Acetylcholine receptors. Revised estimates of extra-junctional receptor density in denervated rat diaphragm. J Gen Physiol 64:468-472.
17. Frei R, Motzing S, Kinkelin I, Schachner M, Koltzenburg M, Martini R (1999) Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J Neurosci 19:6058-6067.
18. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR (2002) Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-561.
19. Gillingwater TH, Ribchester RR (2001) Compartmental neurodegeneration and synaptic plasticity in the Wld(s) mutant mouse. J Physiol (Lond) 534:627-639.
20. Glavinovic MI (1979) Voltage clamping of unparalysed cut rat diaphragm for study of transmitter release. J Physiol (Lond) 290:467-480.
21. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave K-A (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
22. Gu Y, Hall ZW (1988) Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscle. Neuron 1:117-125.
23. Herndon RM (2002) Medical hypothesis: why secondary progressive multiple sclerosis is a relentlessly progressive illness. Arch Neurol 59:301-304.
24. Katz B, Miledi R (1973) The binding of acetylcholine to receptors and its removal from the synaptic cleft. J Physiol (Lond) 231:549-574.
25. Kidokoro Y (1980) Developmental changes of spontaneous synaptic potential properties in the rat neuromuscular contact formed in culture. Dev Biol 78:231-241.
26. Kopp DM, Perkel DJ, Balice-Gordon RJ (2000a) Disparity in neurotransmitter release probability among competing inputs during neuromuscular synapse elimination. J Neurosci 20:8771-8779.
27. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
28. Lichtman JW, Colman H (2000) Synapse elimination and indelible memory. Neuron 25:269-278.
29. McLachlan EM, Martin AR (1981) Non-linear summation of end-plate potentials in the frog and mouse. J Physiol (Lond) 311:307-324.
30. McMahan UJ (1990) The agrin hypothesis. Cold Spring Harb Symp Quant Biol 55:407-418.
31. Mitsumoto H, Ikeda K, Holmlund T, Greene T, Cedarbaum JM, Wong V, Lindsay RM (1994) The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 36:142-148.
32. Noakes PG, Gautam M, Mudd J, Sanes JR, Merlie JP (1995) Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin beta 2. Nature 374:258-262.
33. Pettmann B, Henderson CE (1998) Neuronal cell death. Neuron 20:633-647.
34. Raff MC, Whitmore AV, Finn JT (2002) Axonal self-destruction and neurodegeneration. Science 296:868-871.
35. Rees D (1978) A non-phosphate-buffered physiological saline for in vitro electrophysiological studies on the mammalian neuromuscular junction. J Physiol (Lond) 278:8P-9P.
36. Ribchester RR, Mao F, Betz WJ (1994) Optical measurements of activity-dependent membrane recycling in motor nerve terminals of mammalian skeletal muscle. Proc R Soc Lond B Biol Sci 255:61-66.
37. Rich MM, Wang X, Cope TC, Pinter MJ (2002) Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease. J Neurophysiol 88:3305-3314.
38. Roy RR, Zhong H, Monti RJ, Vallance KA, Kim JA, Edgerton VR (2000) Mechanical properties and fiber type composition of chronically inactive muscles. J Gravit Physiol 7:103-104.
39. Sack Jr GH, Cork LC, Morris JM, Griffin JW, Price DL (1984) Autosomal dominant inheritance of hereditary canine spinal muscular atrophy. Ann Neurol 15:369-373.
40. Sahenk Z, Chen L, Mendell JR (1999) Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 45:16-24.
41. Sancho S, Magyar JP, Aguzzi A, Suter U (1999) Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 122:1563-1577.
42. Sanes JR, Lichtman JW (1999) Development of the vertebrate neuromuscular junction. Annu Rev Neurosci 22:389-442.
43. Scherer S (1999) Axonal pathology in demyelinating diseases. Ann Neurol 45:6-7.
44. Son YJ, Thompson WJ (1995) Schwann cell processes guide regeneration of peripheral axons. Neuron 14:125-132.
45. Tonge DA (1974) Chronic effects of botulinum toxin on neuromuscular transmission and sensitivity to acetylcholine in slow and fast skeletal muscle of the mouse. J Physiol (Lond) 241:127-139.
46. Trachtenberg JT, Thompson WJ (1997) Nerve terminal withdrawal from rat neuromuscular junctions induced by neuregulin and Schwann cells. J Neurosci 17:6243-6255.
47. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
48. Trapp BD, Ransohoff RM, Fisher E, Rudick RA (1999) Neurodegeneration in multiple sclerosis: relationship to neurological disability. The Neuroscientist 5:48-57.
49. 0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 17:451-460.
50. Weinstein SP (1980) A comparative electrophysiological study of motor end-plate diseased skeletal muscle in the mouse. J Physiol (Lond) 307:453-464.
51. Wrabetz L, Feltri ML, Quattrini A, Imperiale D, Previtali S, D'antonio M, Martini R, Yin X, Trapp BD, Zhou L, Chiu SY, Messing A (2000) P0 glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 148:1021-1034.
52. Yin X, Crawford TO, Griffin JW, Tu P-H, Lee VMY, Li C, Roder J, Trapp BD (1998) Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18:1953-1962.
53. Yin X, Kidd GJ, Wrabetz L, Feltri ML, Messing A, Trapp BD (2000) Schwann cell myelination requires timely and precise targeting of P0 protein. J Cell Biol 148:1009-1020.